The Department of Justice has filed a lawsuit against Walgreens Boots Alliance (WBA), claiming the pharmacy chain filled millions of unlawful prescriptions for controlled substances in violation of federal law. The suit, which seeks up to $80,850 in civil penalties per invalid prescription, also alleges that pharmacists ignored “red flags” and filled prescriptions too quickly.
Walgreens counters that it has implemented protocols for reporting suspicious prescribers and believes that pharmacists should not have to second-guess doctors who have been approved by the Drug Enforcement Administration. The company is seeking clarification on the responsibilities of pharmacies and pharmacists, arguing that the government’s attempt to enforce arbitrary “rules” does not exist.
The lawsuit comes as Walgreens stock tumbled 9.2% in early trading, reversing a recent surge. Analysts note that while opioids remain a concern for the pharmacy industry, it is unlikely to be a near-term risk. However, if the allegations are proven true, it could result in significant financial penalties for Walgreens.
Other retail pharmacies, including Walmart and CVS, have faced similar lawsuits from the DOJ over opioid prescriptions. The case highlights the ongoing challenges facing the pharmacy industry in addressing the opioid crisis.
Source: https://www.investors.com/news/technology/walgreens-stock-doj-lawsuit-walmart-cvs-rite-aid